{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:15:14Z","timestamp":1784297714324,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bulcan.2025.10.007","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:25:55Z","timestamp":1765887955000},"page":"273-278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gestational trophoblastic diseases and neonatal choriocarcinoma"],"prefix":"10.1016","volume":"113","author":[{"given":"C\u00e9cile","family":"Faure-Conter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelique","family":"Rome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Orbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Adrien","family":"Bolze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2025.10.007_bib0215","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/cas.16102","article-title":"Cross-individual cancer transmission to children during the gestational and perinatal periods","volume":"115","author":"Arakawa","year":"2024","journal-title":"Cancer Sci"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0220","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S1470-2045(03)01245-2","article-title":"Epidemiology and aetiology of gestational trophoblastic diseases","volume":"4","author":"Altieri","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0225","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.hoc.2024.07.003","article-title":"Epidemiology of gestational trophoblastic disease","volume":"38","author":"Joneborg","year":"2024","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0230","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1093\/humrep\/dev169","article-title":"Risk of recurrent molar pregnancies following complete and partial hydatidiform moles","volume":"30","author":"Eagles","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0235","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.ejca.2015.05.026","article-title":"Formalised consensus of the European Organisation for Treatment of Trophoblastic Diseases on management of gestational trophoblastic diseases","volume":"51","author":"Bolze","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0240","doi-asserted-by":"crossref","first-page":"401.e1","DOI":"10.1016\/j.ajog.2021.05.006","article-title":"Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in a retrospective cohort of 7761 patients in France","volume":"225","author":"Descargues","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0245","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/1471-0528.13617","article-title":"Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review","volume":"123","author":"Braga","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0250","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/ng1740","article-title":"Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans","volume":"38","author":"Murdoch","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0255","doi-asserted-by":"crossref","first-page":"e170669","DOI":"10.1172\/JCI170669","article-title":"Defects in meiosis I contribute to the genesis of androgenetic hydatidiform moles","volume":"134","author":"Rezaei","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0260","doi-asserted-by":"crossref","first-page":"362.e1","DOI":"10.1016\/j.ajog.2023.09.006","article-title":"Multiple pregnancy with complete hydatidiform mole and coexisting normal fetus in a retrospective cohort of 141 patients","volume":"230","author":"Hajri","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0265","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1093\/humrep\/der265","article-title":"Contribution of referent pathologists to the quality of trophoblastic diseases diagnosis","volume":"26","author":"Golfier","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0270","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1097\/PAS.0000000000000937","article-title":"Choriocarcinoma in women: analysis of a case series with genotyping","volume":"41","author":"Savage","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0275","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/1471-0528.16202","article-title":"Demographics, natural history and treatment outcomes of non-molar gestational choriocarcinoma: a UK population study","volume":"127","author":"Savage","year":"2020","journal-title":"BJOG"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0280","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/ijgc-00009577-200101000-00011","article-title":"The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment","volume":"11","author":"Kohorn","year":"2001","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0285","first-page":"102890","article-title":"Prognosticating gestational trophoblastic neoplasia: from FIGO 2000 to future models","volume":"77","author":"Jin-Kai","year":"2024","journal-title":"E Clin Med"},{"issue":"10","key":"10.1016\/j.bulcan.2025.10.007_bib0290","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.annonc.2025.06.006","article-title":"Efficacy and safety of biweekly single-dose actinomycin D vs. multiday methotrexate in low-risk gestational trophoblastic neoplasia: a prospective multicenter randomized trial","volume":"36","author":"Jiang","year":"2025","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0295","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ygyno.2018.05.030","article-title":"First-line hysterectomy for women with low-risk non-metastatic gestational trophoblastic neoplasia no longer wishing to conceive","volume":"150","author":"Bolze","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0300","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1097\/IGC.0000000000001367","article-title":"Outcome of first-line hysterectomy for gestational trophoblastic neoplasia in patients no longer wishing to conceive and considered with isolated lung metastases: a series of 30 patients","volume":"28","author":"Dabi","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0305","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ygyno.2015.01.530","article-title":"Brain metastases in gestational trophoblast neoplasia: an update on incidence, management and outcome","volume":"137","author":"Savage","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0310","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1200\/JCO.2014.57.5332","article-title":"Effects of single-agent and combination chemotherapy for gestational trophoblastic tumors on risks of second malignancy and early menopause","volume":"33","author":"Savage","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0315","doi-asserted-by":"crossref","first-page":"390.e1-8","DOI":"10.1016\/j.ajog.2015.09.083","article-title":"Mortality rate of gestational trophoblastic neoplasia with a FIGO score of\u00a0\u2265\u00a013","volume":"214","author":"Bolze","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0320","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10147-018-1337-9","article-title":"Gestational trophoblastic neoplasia with brain metastasis at initial presentation: a retrospective study","volume":"24","author":"Gavanier","year":"2019","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0325","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/sj.bjc.6603608","article-title":"A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia","volume":"96","author":"Powles","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0330","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1200\/JCO.2012.43.1817","article-title":"EMA\/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis","volume":"31","author":"Alifrangis","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0335","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/IGC.0000000000000892","article-title":"PD-L1 expression in premalignant and malignant trophoblasts from gestational trophoblastic diseases is ubiquitous and independent of clinical outcomes","volume":"27","author":"Bolze","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0340","doi-asserted-by":"crossref","first-page":"381.e1","DOI":"10.1016\/j.ajog.2024.09.115","article-title":"Fc\u03b3R3A polymorphism influences natural killer cell activation and response to anti-PD-L1 (avelumab) in gestational trophoblastic neoplasia","volume":"232","author":"Msika","year":"2025","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0345","doi-asserted-by":"crossref","first-page":"S545","DOI":"10.1016\/j.annonc.2024.08.772","article-title":"711O Avelumab\u00a0+\u00a0methotrexate to eradicate low-risk gestational trophoblastic tumors in first-line setting: TROPHAMET phase I\/II trial","volume":"35","author":"You","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0350","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1200\/JCO.20.00803","article-title":"Avelumab in patients with gestational trophoblastic tumors with resistance to single-agent chemotherapy: cohort A of the TROPHIMMUN Phase II Trial","volume":"38","author":"You","year":"2020","journal-title":"JCO"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0355","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/S0140-6736(17)32894-5","article-title":"Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia","volume":"390","author":"Ghorani","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0360","first-page":"101974","article-title":"Anti-PD-1 therapy plus chemotherapy versus anti-PD-1 therapy alone in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia: a multicenter, retrospective study","volume":"59","author":"Wang","year":"2023","journal-title":"E Clin Med"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0365","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2020.02.011","article-title":"Practical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic disease","volume":"130","author":"Lok","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0370","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41416-019-0402-0","article-title":"Intensified therapies improve survival and identification of novel prognostic factors for placental-site and epithelioid trophoblastic tumours","volume":"120","author":"Froeling","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0375","doi-asserted-by":"crossref","first-page":"e31124","DOI":"10.1002\/pbc.31124","article-title":"Choriocarcinoma in neonates and infants: a severe but curable disease","volume":"71","author":"Castex","year":"2024","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0380","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1016\/j.ajog.2013.07.002","article-title":"First confirmation by genotyping of transplacental choriocarcinoma transmission","volume":"209","author":"Bolze","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0385","first-page":"104652","article-title":"Cutaneous manifestation of metastatic infantile choriocarcinoma","volume":"2014","author":"Brooks","year":"2014","journal-title":"Case Rep Pediatr"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0390","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00247-018-4115-y","article-title":"Cutaneous metastases of infantile choriocarcinoma can mimic infantile hemangioma both clinically and radiographically","volume":"48","author":"Dance","year":"2018","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00431-003-1361-1","article-title":"Unexplained anaemia and failure to thrive as initial symptoms of infantile choriocarcinoma: a review","volume":"163","author":"Blohm","year":"2004","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0400","doi-asserted-by":"crossref","first-page":"e30117","DOI":"10.1002\/pbc.30117","article-title":"Extracranial germ cell tumours in children and adolescents: results from the French TGM13 protocol","volume":"70","author":"Faure-Conter","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0405","unstructured":"Reference Center on Teratogenic Agents. https:\/\/www.lecrat.fr\/ n.d."},{"key":"10.1016\/j.bulcan.2025.10.007_bib0410","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1089\/bfm.2018.0078","article-title":"High-dose methotrexate treatment in a breastfeeding mother with placenta accreta: a case report","volume":"13","author":"Baker","year":"2018","journal-title":"Breastfeed Med"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0415","doi-asserted-by":"crossref","first-page":"115354","DOI":"10.1016\/j.biopha.2023.115354","article-title":"High accumulation of nivolumab in human breast milk: a case report","volume":"166","author":"de Jong","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bulcan.2025.10.007_bib0420","doi-asserted-by":"crossref","first-page":"e245625","DOI":"10.1001\/jamanetworkopen.2024.5625","article-title":"Immune checkpoint inhibitor use during pregnancy and outcomes in pregnant individuals and newborns","volume":"7","author":"Gougis","year":"2024","journal-title":"JAMA Netw Open"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455125005235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455125005235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:30:27Z","timestamp":1770820227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455125005235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0007455125005235"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2025.10.007","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gestational trophoblastic diseases and neonatal choriocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2025.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}